DE259714C - - Google Patents
Info
- Publication number
- DE259714C DE259714C DENDAT259714D DE259714DA DE259714C DE 259714 C DE259714 C DE 259714C DE NDAT259714 D DENDAT259714 D DE NDAT259714D DE 259714D A DE259714D A DE 259714DA DE 259714 C DE259714 C DE 259714C
- Authority
- DE
- Germany
- Prior art keywords
- preparations
- mixture
- pure
- rays
- thorium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 229910052684 Cerium Inorganic materials 0.000 claims description 5
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims description 5
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 claims description 4
- 229910052776 Thorium Inorganic materials 0.000 claims description 4
- 239000000126 substance Substances 0.000 description 3
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 2
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 229940036348 bismuth carbonate Drugs 0.000 description 1
- GMZOPRQQINFLPQ-UHFFFAOYSA-H dibismuth;tricarbonate Chemical compound [Bi+3].[Bi+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O GMZOPRQQINFLPQ-UHFFFAOYSA-H 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079905 intestinal adsorbents bismuth preparations Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE259714C true DE259714C (OSRAM) |
Family
ID=517418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT259714D Active DE259714C (OSRAM) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE259714C (OSRAM) |
-
0
- DE DENDAT259714D patent/DE259714C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3845000C2 (de) | Anwendung von Octreotid zur Behandlung von Brustkrebs | |
| DE3781078T2 (de) | Verwendunng eines peptids zur herstellung von zusammensetzungen fuer die linderung, behandlung und diagnose von autoimmunkrankheiten, insbesondere arthritis, zu diesem peptid analoge verbindungen, mikro-organismen, die dieses peptid oder eine zu diesem peptid analoge verbindung produzieren, als auch pharmazeutische und diagnostische zusammensetzungen und test kits. | |
| Sprunt et al. | STUDIES ON THE RELATIONSHIP OF THE SEX HORMONES TO INFECTION: I. THE EFFECT OF THE ESTROGENIC AND GONADOTROPIC HORMONES ON VACCINIA AND THE SPREADING FACTOR | |
| EP0023994A2 (de) | Zahnmedizinische Wurzelfüllpaste | |
| DE69532112T2 (de) | Vverwendung von mcp-1zur induktion der reifung des gebärmutterhalses | |
| DE259714C (OSRAM) | ||
| DE2348221B2 (de) | Peptide, die eine regelung der sexualhormonkonzentration im blut bewirken, und verfahren zu deren herstellung | |
| Rydbero et al. | The effect of gonadotropic hormone treatment in cases of amenorrhoea: Production of true menstruation and increased excretion of oestrin | |
| DE69803059T2 (de) | Pharmazeutische zusammensetzung enthaltend uscharin | |
| DE714146C (de) | Textilweichmachungsmittel | |
| DE3240044A1 (de) | Verwendung von 17(alpha)-acyloxy-6-methylpregna-4,6-dien-3,20-dionen zur bekaempfung von brustkrebs | |
| DE3216026A1 (de) | Technetium(99m)-markiertes isonicotinsaeurehydrazid, verfahren zu dessen herstellung und ein pharmazeutisches mittel, das diese verbindung enthaelt | |
| Perry | , et al. Perry RJ | |
| DE257473C (OSRAM) | ||
| DE548060C (de) | Schutzvorrichtung gegen die aus dem Koerper des bestrahlten Patienten austretenden Roentgenstrahlen | |
| AT205175B (OSRAM) | ||
| DE2508338C2 (de) | Verwendung von Lösungen von Friedelan-3-on bei der Krebsbekämpfung | |
| Macht et al. | Pharmacology of Ruvettus Pretiosus, or “Castor-Oil Fish.” | |
| DE2205920C3 (de) | Sedativ und hypnotisch wirksames Arzneimittel | |
| Mas Bakal et al. | Investigation into the occurrence of Toxoplasma in pharyngeal and palatine tonsils by inoculation of tonsillar tissues into mice | |
| DE2449653A1 (de) | Tiermastmittel | |
| Kim et al. | Computed tomography in evaluation of jaundiced patients due to clonorchis sinensis | |
| Brix et al. | Diagnostic evaluation of the breast using PET: optimization of data acquisition and postprocessing | |
| Biersack et al. | Bone Metastases of Prostatic Cancer in Relation to Tumor Size and Grade of Malignancy | |
| DE2039169A1 (de) | Verfahren zur Kontrolle der Fertilitaet |